McPhadden Samac Tuovi LLP has commenced a proposed Invokana class action.

Invokana is used in the  treatment of type 2 diabetes.  

There are reports that Invokana causes injuries such as diabetic ketoacidosis, kidney failure, and

heart attack.

In the lawsuit, it is the plaintiff’s position that patients and their prescribing physicians were not

adequately warned about these possible injuries.

If you or someone you know has suffered a personal injury while taking Invokana and would like

to receive further information about this lawsuit and proposed Invokana class action, please

complete our online registration form.  Registration will enable us to readily provide case

updates and collect claimant information.

Potential claimants should obtain for safekeeping at this time copies of their pharmacy

prescription histories and medical records.

Note that registration does not give rise to a lawyer-client relationship.  Execution of our retainer

agreement is necessary to establish a lawyer-client relationship.

CLICK HERE TO REGISTER